Literature DB >> 17027851

Dyssynchronous (non-uniform) Ca2+ release in myocytes from streptozotocin-induced diabetic rats.

Chun-Hong Shao1, George J Rozanski, Kaushik P Patel, Keshore R Bidasee.   

Abstract

Using biochemical/pharmacological approaches, we previously showed that type 2 ryanodine receptors (RyR2) become dysfunctional in hearts of streptozotocin-induced type 1 diabetic rats. However, the functional consequence of this observation remains incompletely understood. Here we use laser confocal microscopy to investigate whether RyR2 dysfunction during diabetes alters evoked and spontaneous Ca(2+) release from the sarcoplasmic reticulum (SR). After 7-8 weeks of diabetes, steady-state levels of RyR2 remain unchanged in hearts of male Sprague-Dawley rats, but the number of functional receptors decreased by >37%. Interestingly, residual functional RyR2 from diabetic rat hearts exhibited increased sensitivity to Ca(2+) activation (EC(50activation) decreased from 80 microM to 40 microM, peak Ca(2+) activation decreased from 425 microM to 160 microM). When field stimulated, intracellular Ca(2+) release in diabetic ventricular myocytes was dyssynchronous (non-uniform) and this was independent of L-type Ca(2+) currents. Time to peak Ca(2+) increased 3.7-fold. Diabetic myocytes also exhibited diastolic Ca(2+) release and 2-fold higher frequency of spontaneous Ca(2+) sparks, albeit at a lower amplitude. The amplitude of caffeine-releasable Ca(2+) was also lower in diabetic myocytes. RyR2 from diabetic rat hearts exhibited increased phosphorylation at Ser2809 and contained reduced levels of FKBP12.6 (calstablin2). Collectively, these data suggest that RyR2 becomes leaky during diabetes and this defect may be responsible to the reduced SR Ca(2+) load. Diastolic Ca(2+) release could also serve as a substrate for delayed after-depolarizations, contributing to the increased incidence of arrhythmias and sudden cardiac death in type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027851     DOI: 10.1016/j.yjmcc.2006.08.018

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  36 in total

1.  Carbonylation induces heterogeneity in cardiac ryanodine receptor function in diabetes mellitus.

Authors:  Chun Hong Shao; Chengju Tian; Shouqiang Ouyang; Caronda J Moore; Fadhel Alomar; Ina Nemet; Alicia D'Souza; Ryoji Nagai; Shelby Kutty; George J Rozanski; Sasanka Ramanadham; Jaipaul Singh; Keshore R Bidasee
Journal:  Mol Pharmacol       Date:  2012-05-30       Impact factor: 4.436

2.  Gain of function of cardiac ryanodine receptor in a rat model of type 1 diabetes.

Authors:  Chengju Tian; Chun Hong Shao; Caronda J Moore; Shelby Kutty; Timothy Walseth; Cyrus DeSouza; Keshore R Bidasee
Journal:  Cardiovasc Res       Date:  2011-03-18       Impact factor: 10.787

Review 3.  Endoplasmic-reticulum calcium depletion and disease.

Authors:  Djalila Mekahli; Geert Bultynck; Jan B Parys; Humbert De Smedt; Ludwig Missiaen
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

Review 4.  Reactive carbonyl species and their roles in sarcoplasmic reticulum Ca2+ cycling defect in the diabetic heart.

Authors:  Chengju Tian; Fadhel Alomar; Caronda J Moore; Chun Hong Shao; Shelby Kutty; Jaipaul Singh; Keshore R Bidasee
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

5.  Carbonylation of myosin heavy chains in rat heart during diabetes.

Authors:  Chun-Hong Shao; George J Rozanski; Ryoji Nagai; Frank E Stockdale; Kaushik P Patel; Mu Wang; Jaipaul Singh; William G Mayhan; Keshore R Bidasee
Journal:  Biochem Pharmacol       Date:  2010-03-30       Impact factor: 5.858

6.  CCDI: a new ligand that modulates mammalian type 1 ryanodine receptor (RyR1).

Authors:  Chengju Tian; Chun Hong Shao; Christina Padanilam; Edward Ezell; Jaipaul Singh; Shelby Kutty; Keshore R Bidasee
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 7.  There goes the neighborhood: pathological alterations in T-tubule morphology and consequences for cardiomyocyte Ca2+ handling.

Authors:  William E Louch; Ole M Sejersted; Fredrik Swift
Journal:  J Biomed Biotechnol       Date:  2010-04-08

Review 8.  Metabolic dysfunction in diabetic cardiomyopathy.

Authors:  Michael Isfort; Sarah C W Stevens; Stephen Schaffer; Chian Ju Jong; Loren E Wold
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

9.  Exercise training initiated after the onset of diabetes preserves myocardial function: effects on expression of beta-adrenoceptors.

Authors:  Keshore R Bidasee; Hong Zheng; Chun-Hong Shao; Sheeva K Parbhu; George J Rozanski; Kaushik P Patel
Journal:  J Appl Physiol (1985)       Date:  2008-06-26

10.  Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes.

Authors:  Caronda J Moore; Chun Hong Shao; Ryoji Nagai; Shelby Kutty; Jaipaul Singh; Keshore R Bidasee
Journal:  Mol Cell Biochem       Date:  2013-01-25       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.